SCHEMBL25925933

SCHEMBL25925933

Cn1nccc1/N=N/c1ccc(O)c(O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
BRD4 O60885 3/20 0.37
MEN1 O00255 7/20 0.35
KMT2A Q03164 7/20 0.35
MAPT P10636 5/20 0.35
HTT P42858 4/20 0.35
TDP1 Q9NUW8 4/20 0.35
AGTR1 P30556 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
AHR P35869 1/20 0.35
PDE4A P27815 1/20 0.35
BLVRB P30043 1/20 0.35
KDR P35968 1/20 0.35
ALDH1A1 P00352 2/20 0.35
HSP90AA1 P07900 3/20 0.34
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
QDPR P09417 1/20 0.33
L3MBTL1 Q9Y468 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18250390 0.88 KMT2A (0.49) BRD4MEN1KMT2AMAPTHTT
SCHEMBL16232517 0.86 PTGS1 (0.46) PTGS1PTGS2BRD4MEN1KMT2A
SCHEMBL15049243 0.86 PTGS1 (0.46) PTGS1PTGS2BRD4MEN1KMT2A
SCHEMBL25925882 0.84 AHR (0.36) BRD4MEN1KMT2AMAPTHTT
SCHEMBL25925733 0.79 ALDH1A1 (0.36) MAPTALDH1A1KDM4C
SCHEMBL25925862 0.78 MAPT (0.34) MEN1KMT2AMAPTHTTTDP1
SCHEMBL25925932 0.75 ESR1 (0.33) MEN1KMT2AMAPTTDP1ALDH1A1
SCHEMBL25925704 0.75 MAPT (0.33) MEN1KMT2AMAPTHTTTDP1
SCHEMBL25925911 0.73 EGFR (0.49) MEN1KMT2AMAPTHTTTDP1
SCHEMBL22650274 0.73 KDR (0.40) PTGS1PTGS2BRD4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 PTGS1 1753/4885PTGS2 3678/4885BRD4 2034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.